Faculty profile

Jensen Yeung

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Toronto

Jensen Yeung

Associate Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
160 publications in the last five years, latest in 2026.
Senior (last) author on 75 recent papers, a sign of leading a research group.
Supervisor on 1 trainee award (1 CIHR), most recently in 2023.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

230

Publications

1,005

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Treatment‐associated phenotype switching between psoriasis and atopic dermatitis
Journal of the European Academy of Dermatology and Venereology · 2026
Just the facts: diagnosis and management of Stevens–Johnson syndrome/toxic epidermal necrolysis
Canadian Journal of Emergency Medicine · 2026 · first author
Dupilumab-Associated Facial and Neck Erythema: An Updated Systematic Review of Management Strategies.
Journal of cutaneous medicine and surgery · 2026

All 230 publications

Latest funding

Investigating the efficacy and safety profiles of Bimekizumab in treating moderate-to-severe plaque psoriasis: A Canadian retrospective study
CIHR · 2023 · Supervisor
$5,000

All 1 grants and awards

From the 150 most recent of 230 publications.

Treatment‐associated phenotype switching between psoriasis and atopic dermatitis

Torres T, Valenti M, Balato A, Megna M, Gisondi P, Prajapati V, Piaserico S, Maul J, Maul LV, Carrascosa JM

Journal of the European Academy of Dermatology and Venereology20262 citationsOpen Access

DOI: 10.1111/jdv.70503

Just the facts: diagnosis and management of Stevens–Johnson syndrome/toxic epidermal necrolysis

Jensen Yeung, Marlene T. Dytoc, Eric Mutter, Jan Peter Dutz

Canadian Journal of Emergency Medicine20261 citationsFirst authorOpen Access

DOI: 10.1007/s43678-025-01041-x PMID: 41493751

Dupilumab-Associated Facial and Neck Erythema: An Updated Systematic Review of Management Strategies.

Jo CE, Sood S, Bagit A, Georgakopoulos JR, Piguet V, Yeung J, Drucker AM

Journal of cutaneous medicine and surgery2026Open Access

DOI: 10.1177/12034754261480639 PMID: 42757760

Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real-World Effectiveness and Safety From a Prospective Cohort.

Lucas Ribeiro A, Al-Zahir Z, Carrizo Abarza V, Maliyar K, Sood S, Bagit A, Sachdeva M, Koppikar S, Gladman DD, Yeung J, Chandran V, Eder L

ACR open rheumatology2026Open Access

DOI: 10.1002/acr2.90084 PMID: 42576419

Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study

Torres T, Sood S, Yilmaz O, Vender RB, Prajapati VH, Puig L, Megna M, Marzano AV, Gisondi P, Carrascosa JM

Dermatology and Therapy2026Senior authorOpen Access

DOI: 10.1007/s13555-026-01653-w

Understanding Cumulative Life Course Impairment in Canadian Patients With Psoriasis

Beecker J, Hong C-H, Veillette H, Vender R, Yeung J, Chandran V, Palmay C

Journal of Cutaneous Medicine and Surgery2026

DOI: 10.1177/12034754251403190

Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis (CAN TARGET PSORIASIS)

Yeung J, Grewal P, Lansang P, Vender R, Wiseman M, Zeinab RA, Barakat M, Prajapati VH

Dermatology and Therapy2026First authorOpen Access

DOI: 10.1007/s13555-026-01734-w

Real-World Effectiveness and Safety of Deucravacitinib for Adult Patients with Plaque Psoriasis: A 16-Week Multicenter Retrospective Study of Monotherapy and Combination Therapy.

Sood S, Bagit A, Maliyar K, Rankin BD, Abduelmula A, Rimke A, Georgakopoulos JR, Leung F, Devani AR, Mufti A

Journal of Cutaneous Medicine and Surgery2026Senior author

DOI: 10.1177/12034754261458397

Application of real-world effectiveness outcomes of upadacitinib to Canadian treat-to-target criteria in atopic dermatitis: A retrospective multicenter analysis of 1-year data.

Waked J, Sood S, Rankin BD, Rimke A, Abduelmula A, Georgakopoulos JR, Maliyar K, Leung F, Devani AR, Yeung J, Prajapati VH

Journal of the American Academy of Dermatology2026

DOI: 10.1016/j.jaad.2026.07.082 PMID: 42526811

Management of Refractory Eosinophilic Fasciitis Using Biologic Therapies, Janus Kinase Inhibitors, and Intravenous Immunoglobulin: A Systematic Review.

Mitwalli M, Waked JAA, Sood S, Abduelmula A, Akuffo-Addo E, Yeung J, Mufti A

Journal of cutaneous medicine and surgery2026

DOI: 10.1177/12034754261470759 PMID: 42504410

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Jensen Yeung

Research

Latest papers

Latest funding

Treatment‐associated phenotype switching between psoriasis and atopic dermatitis

Just the facts: diagnosis and management of Stevens–Johnson syndrome/toxic epidermal necrolysis

Dupilumab-Associated Facial and Neck Erythema: An Updated Systematic Review of Management Strategies.

Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real-World Effectiveness and Safety From a Prospective Cohort.

Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study

Understanding Cumulative Life Course Impairment in Canadian Patients With Psoriasis

Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis (CAN TARGET PSORIASIS)

Real-World Effectiveness and Safety of Deucravacitinib for Adult Patients with Plaque Psoriasis: A 16-Week Multicenter Retrospective Study of Monotherapy and Combination Therapy.

Application of real-world effectiveness outcomes of upadacitinib to Canadian treat-to-target criteria in atopic dermatitis: A retrospective multicenter analysis of 1-year data.

Management of Refractory Eosinophilic Fasciitis Using Biologic Therapies, Janus Kinase Inhibitors, and Intravenous Immunoglobulin: A Systematic Review.

Investigating the efficacy and safety profiles of Bimekizumab in treating moderate-to-severe plaque psoriasis: A Canadian retrospective study

Frequent collaborators

Asfandyar Mufti

Khalad Maliyar

Ronald Vender

Perla Lansang

Vincent Piguet

Geeta Yadav

Aaron Drucker

Yvette Miller-Monthrope

Scott Walsh

Ivan Litvinov

Vinod Chandran

Lihi Eder

Sameh Hanna

Marissa Joseph

Daniel Wong

Dana Jerome

Maxwell Sauder

Judy Qiang

Anastasiya Muntyanu

Jennifer Salsberg

Harvey Lui

Vipul Jain

Carolyn Jack

Robert Gniadecki

Philippe Lefrançois

Jan Dutz

Dafna Gladman

Richard Cook

Elena Pope

Mark Silverberg

David Croitoru

Paivi Miettunen

Loretta Fiorillo

Jaggi Rao

Sandra Viero